SCHEMBL649312

SCHEMBL649312

Cc1cc(OCCN2CCOCC2)ccc1/N=C1/NC(=O)/C(=C/c2cnc(C3CCCCN3)s2)S1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
KDR P35968 1/20 0.38
ALOX5 P09917 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 4/20 0.36
NPSR1 Q6W5P4 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CCR4 P51679 1/20 0.35
MAOA P21397 1/20 0.34
PARP1 P09874 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649314 1.00 HPGD (0.43) HPGDKDRALOX5MEN1KMT2A
SCHEMBL650961 0.87 MAPT (0.38) HPGDMEN1KMT2AMAPTNPSR1
SCHEMBL650959 0.87 MAPT (0.38) HPGDMEN1KMT2AMAPTNPSR1
SCHEMBL651184 0.83 MAPT (0.38) HPGDMEN1KMT2ANPC1MAPT
SCHEMBL651186 0.83 MAPT (0.38) HPGDMEN1KMT2ANPC1MAPT
SCHEMBL10176552 0.83 HPGD (0.47) HPGDKDRALOX5MEN1KMT2A
SCHEMBL649313 0.83 HPGD (0.47) HPGDKDRALOX5MEN1KMT2A
SCHEMBL649545 0.82 HPGD (0.44) HPGDKDRALOX5MEN1KMT2A
SCHEMBL10176445 0.82 HPGD (0.44) HPGDKDRALOX5MEN1KMT2A
SCHEMBL652913 0.81 HPGD (0.46) HPGDKDRALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423204-A1 THIAZOLIDINONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2012-02-29 EP disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 HPGD 3970/4885KDR 4523/4885ALOX5 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.